Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4555 Assessment of gastric mucosa conditions changes in patients with gastric neuroendocrine neoplasia type 1 during gastroprotective therapy

Introduction: Currently, the incidence of gastric neuroendocrine neoplasia (gNEN) has increased significantly. Most gNEN are developed on the background of chronic atrophic gastritis (about 90%). Despite this, the role of chronic atrophic gastritis treatment (gastroprotective therapy) in dynamic of gNEN remains unexplored.

Conference:

Presenting Author: Konyakhina A

Authors: Konyakhina A, Feidorov I, Salimgereeva D, Petrova A,

Keywords: gNEN, atrophic gastritis, OLGA, rebamipide,

#4354 Analysis of gastric NENS in the Czech neuroendocrine tumour registry (2009-2024)

Introduction: Czech Neuroendocrine Tumour Registry is collecting data of NEN patients and their treatment since 2009. We have already analysed SI NENs, pancreatic and thymic NENs. Now we focused on analysis of gastric NENs.

Conference:

Presenting Author:

Authors: Barkmanova J, Sedlackova E,

Keywords: registry, gastric neuroendocrine neoplasia,

#4154 Gastric mucosa conditions during atrophic gastritis and gastric neuroendocrine neoplasia type 1 (gNEN 1)

Introduction: Worldwide frequency of neuroendocrine tumors increased, which is associated with improved approaches to the diagnosis of chronic diseases of the upper digestive tract. Management of these neoplasms in real clinical practice can be difficult.

Conference:

Presenting Author: Konyakhina A

Authors: Konyakhina A, Feidorov I, Salimgereeva D,

Keywords: gNEN, atrophic gastritis, OLGA, rebamipide,

#3135 Endoscopic resection of type I gastric neuroendocrine neoplasia (NEN): A systematic review

Introduction: Although relatively uncommon, the incidence of type I gastric NEN has been rising over time. Since they are considered indolent neoplasms, with a low metastatic potential, endoscopic resection is the treatment of choice. However, correct endoscopic management is not well established.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Magi L, Esposito G, Rinzivillo M, Annibale B, Panzuto F,

Keywords: gastric carcinoid, gastric neuroendocrine neoplasia, gastric neuroendocrine tumor, endoscopic resection, mucosal resection, submucosal dissection, polipectomy,

#2815 Unexpected High Rate of Metastases in Type 1 Gastric Neuroendocrine Neoplasia

Introduction: Gastric neuroendocrine neoplasms (gNEN) represent about 7.5% of gastroenteropancreatic NEN (gepNEN), classified in: type 1 (70-80%), related to autoimmune gastritis, type 2 (5%), related to Zollinger-Ellison syndrome in multiple endocrine neoplasia 1 and type 3 (15-20%), in absence of hypergastrinemia or mucosal atrophy.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Bottiglieri F, Modica R, de Cicco F, Minotta R, Faggiano A,

Keywords: gastric, neuroendocrine, type1, type3, metastases,